passenger deletions generate therapeutic vulnerabilities cancer
inactivation tumour-suppressor genes homozygous deletion prototypic event cancer genome yet deletions often encompass neighbouring genes propose homozygous deletions passenger genes can expose cancer-specific therapeutic vulnerabilities collaterally deleted gene member functionally redundant family genes carrying essential function glycolytic gene enolase eno1 1p36 locus deleted glioblastoma gbm tolerated expression eno2 show short-hairpin-rna-mediated silencing eno2 selectively inhibits growth survival tumorigenic potential eno1-deleted gbm cells enolase inhibitor phosphonoacetohydroxamate selectively toxic eno1-deleted gbm cells relative eno1-intact gbm cells normal astrocytes principle collateral vulnerability applicable passenger-deleted genes encoding functionally redundant essential activities provide effective treatment strategy cancers containing genomic events
